Bampton P A, Holloway R H
Royal Adelaide Hospital, SA.
Aust N Z J Med. 1996 Dec;26(6):793-9. doi: 10.1111/j.1445-5994.1996.tb00627.x.
Current practice is to investigate routinely both upper and lower gastrointestinal tracts in patients with unexplained iron deficiency anaemia.
To determine the efficacy of this approach and whether the use of more stringent biochemical criteria for iron deficiency, symptoms, or a positive immunochemical faecal human haemoglobin (FHH) influenced the findings of the investigations and could help target investigations more efficiently.
Eighty patients were studied prospectively, 51 who had "definite' iron deficiency anaemia (low ferritin and transferrin saturation) and 29 with "probable' iron deficiency anaemia (either low ferritin or transferrin saturation). Patients underwent a standardised symptom assessment and testing for FHH, upper endoscopy with small bowel biopsy and colonoscopy, and a small bowel series if upper endoscopy and colonoscopy were negative.
Lesions potentially causative for iron deficiency anemia were found in 54/80 (60%) of patients. Five patients (7%) had lesions in both upper and lower tracts. Small bowel biopsy was abnormal in one of 80 patients and small bowel series one of 25 patients. Significant lesions in either the upper or lower gastrointestinal tract were found in 14/20 patients with positive FHH and 25/47 with negative FHH. Symptoms, use of non-steroidal anti-inflammatory drugs and classification of patients into "definite' and "probable' iron deficiency did not influence yield of investigations or site of lesions found.
Gastrointestinal lesions are common in patients with unexplained iron deficiency anaemia. Neither symptoms nor presence of FHH predict the presence of site of detectable lesions and neither testing for FHH nor more stringent biochemical criteria for iron deficiency alters clinical decision making. The findings support the routine performance of both upper endoscopy and colonoscopy in the investigation of patients with unexplained iron deficiency anaemia, however routine investigation of the small bowel is of questionable value.
目前的做法是对不明原因的缺铁性贫血患者常规检查上、下消化道。
确定这种方法的有效性,以及使用更严格的缺铁生化标准、症状或免疫化学粪便人血红蛋白(FHH)阳性是否会影响检查结果,并有助于更有效地确定检查目标。
对80例患者进行前瞻性研究,其中51例患有“明确的”缺铁性贫血(铁蛋白和转铁蛋白饱和度低),29例患有“可能的”缺铁性贫血(铁蛋白或转铁蛋白饱和度低)。患者接受标准化症状评估和FHH检测、上消化道内镜检查及小肠活检和结肠镜检查,若上消化道内镜检查和结肠镜检查结果为阴性,则进行小肠造影。
80例患者中有54例(60%)发现了可能导致缺铁性贫血的病变。5例(7%)患者上、下消化道均有病变。80例患者中有1例小肠活检异常,25例患者中有1例小肠造影异常。FHH阳性的20例患者中有14例、FHH阴性的47例患者中有25例在上消化道或下消化道发现明显病变。症状、非甾体抗炎药的使用以及将患者分为“明确的”和“可能的”缺铁性贫血,均未影响检查结果或发现病变的部位。
不明原因的缺铁性贫血患者中胃肠道病变很常见。症状和FHH的存在均不能预测可检测病变的部位,FHH检测和更严格的缺铁生化标准均不会改变临床决策。这些发现支持对不明原因的缺铁性贫血患者常规进行上消化道内镜检查和结肠镜检查,然而对小肠进行常规检查的价值值得怀疑。